XML 27 R18.htm IDEA: XBRL DOCUMENT v3.20.2
EQUITY INVESTMENT AND ROYALTIES - Schedule of Stock Options, Valuation Assumptions (Details) - Cell MedX Corp. [Member]
9 Months Ended
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Risk-free rate (%) 0.13%
Expected stock price volatility (%) 182.74%
Expected dividend yield (%) 0.00%
Expected life of options (years) 2 years 3 months 29 days